Ticagrelor versus Clopidogrel in Patients with Acute Coronary SyndromesLars Wallentin, Robert A. Harrington, Richard C. Becker et al.|New England Journal of Medicine|2009Cited by 7.1k
Alirocumab and Cardiovascular Outcomes after Acute Coronary SyndromeGregory G. Schwartz, Andreas M. Zeiher, Shaun G. Goodman et al.|New England Journal of Medicine|2018Cited by 3.5k
Effect of Platelet Inhibition with Cangrelor during PCI on Ischemic EventsDeepak L. Bhatt, Robert A. Harrington, Gregg W. Stone et al.|New England Journal of Medicine|2013Cited by 825
Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary SyndromesPierluigi Tricoci, Kenneth W. Mahaffey, Zhen Huang et al.|New England Journal of Medicine|2011Cited by 753
Intravenous Platelet Blockade with Cangrelor during PCIDeepak L. Bhatt, Robert A. Harrington, A. Michael Lincoff et al.|New England Journal of Medicine|2009Cited by 643